SCHEDULE: James Russell Trust Discloses 5.3% Stake in Abeona

The James Russell Revocable Trust has disclosed a 5.3% beneficial ownership stake in Abeona Therapeutics Inc., holding 2,720,875 shares of Class A Common Stock.

Summary

• The James Russell Revocable Trust reported beneficial ownership of 2,720,875 shares of Abeona Therapeutics Inc. Class A Common Stock.
• This ownership represents 5.3% of the Class A Common Stock outstanding.
• The filing was made under Schedule 13G, indicating a passive investment purpose, not for changing or influencing control of the issuer.
• The Trust holds sole voting power and sole dispositive power over all 2,720,875 shares.
• The date of the event which required the filing of this statement is 09/16/2025.

Sentiment

Score: 6

Explanation: The disclosure of a new significant beneficial owner (5.3%) is generally viewed as a moderately positive signal, indicating investor confidence, even if the stake is passive.

Positives

• A new significant investor, James Russell Revocable Trust, has taken a 5.3% stake in Abeona Therapeutics Inc., which can be viewed as a vote of confidence in the company's prospects.

Negatives

• The filing does not provide any specific details regarding the investment thesis or future plans of the James Russell Revocable Trust beyond its passive investment intent.

Risks

• The securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance from Abeona Therapeutics Inc. or the reporting person regarding the company's future performance or strategic direction.

Management Comments

• James Russell Revocable Trust is the reporting entity. James Russell, Trustee, is the control person.

Industry Context

This filing is a standard disclosure of a significant ownership stake by an investor. It does not provide specific insights into broader industry trends or competitive landscape for Abeona Therapeutics Inc., which operates in the biotechnology sector.

Stakeholder Impact

• Shareholders may perceive the entry of a new significant investor as a positive development, potentially boosting confidence in the company's stock.

Key Dates

Keywords

Abeona Therapeutics, James Russell Revocable Trust, Beneficial Ownership, Class A Common Stock, SEC Filing, Schedule 13G, Biotechnology, Investment